Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | iCRT-14 |
| Synonyms | |
| Therapy Description |
iCRT-14 inhibits the interaction of CTNNB1 with TCF7L2 to block Wnt signaling and results in inhibition of cell proliferation (PMID: 24188694). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| iCRT-14 | CTNNB1 Inhibitor 27 | iCRT-14 inhibits the interaction of CTNNB1 with TCF7L2 to block Wnt signaling and results in inhibition of cell proliferation (PMID: 24188694). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| APC inact mut | colon cancer | sensitive | iCRT-14 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, iCRT-14 induced cell-cycle arrest and inhibited proliferation of colon cancer cells harboring APC inactivating mutations in culture and decreased initial tumor growth in APC-mutant colon cancer cell line xenograft models (PMID: 21393571). | 21393571 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|